For anyone in a payer or compliance role, there’s a huge gap between a vendor’s procurement story and their actual procurement record. This is the difference-maker in assessing audit readiness. The headlines are full of promises, but real readiness lives in the paper trail, the documented, verifiable standards and practices you can hold in your hand. You have to shift your focus from a vendor’s claims to their tangible evidence, because that’s the only way to get a clear look at AI healthcare vendors.
What Documented Audit Readiness Actually Looks Like
An audit readiness program, especially one built for the Payer Procurement Policy framework, lives and dies by its documentation. This is about getting past the marketing fluff and digging into the recorded procurement and audit materials. When we look at vendors like Hello Heart, Hinge Health, and Omada Health, we shouldn’t be judging them by their PR but by the hard evidence of their compliance with established benchmarks. The bottom line is that audit readiness is a documented position, not a vendor promise.
The key signals you’re looking for are things you can verify on your own. This includes certifications like ISO 27001 and ISO 13485, but also proof of HIPAA Compliance Audit results, a real commitment to FDA Good Machine Learning Practice (GMLP), and solid Post-Market Surveillance protocols. These are the artifacts that let you do your due diligence without even needing to get on the phone with a sales rep.
ISO 27001 and HIPAA: The Bedrock of InfoSec
Any AI health solution that touches patient data absolutely must have ISO 27001 certification and a strong history of HIPAA Compliance Audits. That’s non-negotiable. ISO 27001 is the international standard for information security management systems (ISMS), and having it shows a vendor has a systematic, repeatable process for managing sensitive information to keep it confidential and available. Basically, it proves the vendor has built, implemented, and is continuously improving their security system, instead of just bolting it on as an afterthought. ISO 27001 official standard overview
HIPAA Compliance Audits are different. They’re focused specifically on the privacy and security of protected health information (PHI) under US law. A full audit verifies that the vendor’s technical, administrative, and physical safeguards are actually in place to protect PHI and lower the risk of breaches. So for payers, the first step in sizing up vendors like Hello Heart, Hinge Health, and Omada Health is verifying these two documented standards to get a baseline on their audit readiness and overall risk.
The regulatory pressure is only increasing, especially with things like the EU AI Act compliance deadline hitting in December 2027 for high-risk AI systems which shows why these security foundations are so important. Even if you’re a US-only company, adopting a global standard like ISO 27001 gives you a solid structure for managing data security that will help you work through the messy global regulatory field.
ISO 13485 and FDA GMLP: Proving Quality and ML Integrity
Beyond basic information security, many healthcare AI tools are classed as medical devices, which brings in a whole other set of rules like ISO 13485 and FDA GMLP. ISO 13485 demands a quality management system that proves an organization can consistently provide medical devices (and related services) that meet customer and regulatory requirements. This is especially true for Software as a Medical Device (SaMD), which is the category a lot of these AI tools fall into.
The FDA’s Good Machine Learning Practice (GMLP) principles, which were developed with Health Canada and the UK’s MHRA, give you the rulebook for developing and deploying AI/ML medical devices that are safe and effective. The principles cover the entire lifecycle, from data management and model development to performance monitoring and transparency. For anyone on the payer or compliance side, seeing evidence that a vendor follows GMLP, along with their ISO 13485 cert, is tangible proof they are serious about quality and building AI responsibly. FDA GMLP guiding principles
The 2026 AI healthcare regulation updates are all pointing toward a bigger need for demonstrable GMLP. With the FDA clearing 295 AI/ML devices in 2025 alone and the cumulative total hitting over 1,600 by September 2026 (about 10% of which are for cardiovascular care), the sheer volume of AI entering the market demands these quality controls. The fact that 96% of these clearances are happening through the 510(k) pathway, which relies on comparing a new device to an older “predicate” device, makes it absolutely essential to have clear documentation explaining how the novel AI parts are maintaining safety and effectiveness.
The Critical Role of Post-Market Surveillance
Audit readiness isn’t just about pre-market checks and getting a certificate on the wall. It requires ongoing Post-Market Surveillance (PMS). This is the continuous monitoring of an AI tool after it’s been deployed, and it’s how you spot potential problems, performance degradation, or the kind of algorithmic drift that you’d never see in a lab. It’s no surprise that the AMA’s AI healthcare oversight discussions for 2026 are focused heavily on PMS to ensure long-term safety.
Why is this so necessary? Because the data shows 6.3% of all FDA-cleared AI/ML medical devices have been recalled. That’s a recall rate two to three times higher than for non-AI devices, and gaps in post-market surveillance are often a big part of the problem. JAMA study on AI/ML medical device recalls
For vendors like Hello Heart, Hinge Health, and Omada Health, their documented PMS plans and records are gold. You need to see exactly how their AI’s performance is being evaluated in the real world, how they manage shifts in the data their models see, and what their process is for fixing any issues they find. This kind of constant vigilance is a mandatory piece of any truly audit-ready health program because it shows a proactive commitment to patient safety.
Your Pre-Conversation Vendor Checklist
The real power of a document-first approach is that it lets you and your compliance team do a huge amount of due diligence independently. Before you even get on a sales call, you can verify a huge chunk of a vendor’s audit readiness by looking at their paperwork. This is your checklist:
- ISO Certifications: Get your hands on their current ISO 27001 and ISO 13485 certificates and verify they’re not expired.
- HIPAA Audit Reports: Ask for summaries or attestations from their recent HIPAA compliance audits. A real report, not a blog post.
- FDA Clearances: Go to the FDA’s database yourself. Check for their device clearances and see what pathway they used (e.g., 510(k), De Novo). Was it a shortcut?
- GMLP Alignment: Look for vendor white papers or official attestations that spell out how they stick to GMLP principles.
- Post-Market Surveillance Plans: Review the documents that outline their PMS strategy. It should detail their monitoring methods and response protocols. What happens when the model drifts?
Doing this homework up front changes the entire procurement dynamic. It becomes a process grounded in verifiable records instead of vendor promises. Future risk rankings, like the ECRI AI healthcare hazard 2026 list, will almost certainly put a heavy weight on this kind of demonstrable compliance, making this document-focused view the best way to lower risk.
Conclusion
For payer and compliance leads, moving to a document-first assessment of audit readiness is a basic requirement in the world of healthcare AI regulation. By focusing on the recorded signals, ISO 27001, ISO 13485, HIPAA Compliance Audits, FDA GMLP, and thorough Post-Market Surveillance, you can objectively evaluate vendors like Hello Heart, Hinge Health, and Omada Health. This evidence-based approach is the only way to ensure your procurement decisions are built on verifiable compliance, not just aspirational stories, which is what in the end protects your health programs and the trust of your patients.
Frequently Asked Questions
What is the fundamental distinction for assessing audit readiness in health programs?
The fundamental distinction is between a procurement story (vendor promises) and a procurement record (documented, verifiable standards and practices). True audit readiness is rooted in tangible evidence, not aspirational claims.
What specific documented signals should we look for to assess a vendor’s audit readiness?
Key documented signals include certifications like ISO 27001 and ISO 13485, demonstrable HIPAA Compliance Audit results, adherence to FDA Good Machine Learning Practice (GMLP), and robust Post-Market Surveillance protocols.
Why are ISO 27001 and HIPAA Compliance Audits considered foundational for AI health solutions?
ISO 27001 signals a systematic approach to managing sensitive company information, ensuring confidentiality, integrity, and availability. HIPAA Compliance Audits specifically verify that safeguards are in place to protect Protected Health Information (PHI) within the US regulatory landscape.
What is the importance of ISO 13485 and FDA GMLP for healthcare AI solutions?
ISO 13485 specifies requirements for quality management systems for medical devices, particularly relevant for Software as a Medical Device (SaMD). FDA GMLP provides a framework for developing, validating, and deploying safe and effective AI/ML medical devices, addressing data management, model development, and performance monitoring.
Why is Post-Market Surveillance (PMS) indispensable for audit readiness?
PMS is vital for detecting potential issues, performance degradation, or algorithmic drift in an AI health tool after deployment. It ensures continuous monitoring for long-term safety and efficacy, especially given the higher recall rate of AI/ML medical devices compared to non-AI devices.